| 1 |
Yang Z, Liu X, Cribbin EM, Kim AM, Li JJ, Yong K. Liver-on-a-chip: Considerations, advances, and beyond. Biomicrofluidics 2022;16:061502. [DOI: 10.1063/5.0106855] [Reference Citation Analysis]
|
| 2 |
Patra S, Singh M, Wasnik K, Pareek D, Gupta PS, Mukherjee S, Paik P. Polymeric Nanoparticle Based Diagnosis and Nanomedicine for Treatment and Development of Vaccines for Cerebral Malaria: A Review on Recent Advancement. ACS Appl Bio Mater 2021;4:7342-65. [PMID: 35006689 DOI: 10.1021/acsabm.1c00635] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 3 |
Anamika J, Nikhar V, Laxmikant G, Priya S, Sonal V, Vyas SP. Nanobiotechnological modules as molecular target tracker for the treatment and prevention of malaria: options and opportunity. Drug Deliv Transl Res 2020;10:1095-110. [PMID: 32378173 DOI: 10.1007/s13346-020-00770-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 4 |
Neves Borgheti-Cardoso L, San Anselmo M, Lantero E, Lancelot A, Serrano JL, Hernández-Ainsa S, Fernàndez-Busquets X, Sierra T. Promising nanomaterials in the fight against malaria. J Mater Chem B 2020;8:9428-48. [PMID: 32955067 DOI: 10.1039/d0tb01398f] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 5 |
Udu R, Oyweri J, Gathirwa J. Antimalarial Activity of Nigella sativa L. Seed Extracts and Selection of Resistance in Plasmodium berghei ANKA in a Mouse Model. J Pathog 2021;2021:6165950. [PMID: 33623718 DOI: 10.1155/2021/6165950] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Das B, Patel P, Nandi A, Verma SK. Nanomedicines and phytochemicals targeting Alzheimer’s disease. Mitochondrial Dysfunction and Nanotherapeutics 2021. [DOI: 10.1016/b978-0-323-85666-9.00001-2] [Reference Citation Analysis]
|
| 7 |
Balogun MO, Akolade JO, Balogun AO. Development of nanocarriers for innovative antimalarial combination strategies. Applications of Nanobiotechnology for Neglected Tropical Diseases 2021. [DOI: 10.1016/b978-0-12-821100-7.00003-0] [Reference Citation Analysis]
|
| 8 |
Kawakami MYM, Zamora LO, Araújo RS, Fernandes CP, Ricotta TQN, de Oliveira LG, Queiroz-Junior CM, Fernandes AP, da Conceição EC, Ferreira LAM, Barros ALB, Aguiar MG, Oliveira AEMFM. Efficacy of nanoemulsion with Pterodon emarginatus Vogel oleoresin for topical treatment of cutaneous leishmaniasis. Biomed Pharmacother 2021;134:111109. [PMID: 33341050 DOI: 10.1016/j.biopha.2020.111109] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Sánchez A, Mejía SP, Orozco J. Recent Advances in Polymeric Nanoparticle-Encapsulated Drugs against Intracellular Infections. Molecules 2020;25:E3760. [PMID: 32824757 DOI: 10.3390/molecules25163760] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 10 |
Deda DK, Iglesias BA, Alves E, Araki K, Garcia CRS. Porphyrin Derivative Nanoformulations for Therapy and Antiparasitic Agents. Molecules 2020;25:E2080. [PMID: 32365664 DOI: 10.3390/molecules25092080] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 11 |
Mvango S, Mthimkhulu N, Fru PN, Pilcher LA, Balogun MO. Physico-chemical characterization of polyethylene glycol-conjugated betulinic acid. FRACTURE AND DAMAGE MECHANICS: Theory, Simulation and Experiment 2020. [DOI: 10.1063/5.0028479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 12 |
Tshweu LL, Shemis MA, Abdelghany A, Gouda A, Pilcher LA, Sibuyi NRS, Meyer M, Dube A, Balogun MO. Synthesis, physicochemical characterization, toxicity and efficacy of a PEG conjugate and a hybrid PEG conjugate nanoparticle formulation of the antibiotic moxifloxacin. RSC Adv 2020;10:19770-80. [DOI: 10.1039/c9ra10872f] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 13 |
Dube A. Nanomedicines for Infectious Diseases. Pharm Res 2019;36:63. [PMID: 30859326 DOI: 10.1007/s11095-019-2603-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
